Hatch-Waxman “Safe Harbor” Could Face Two-Front Battle In Supreme Court
This article was originally published in The Pink Sheet Daily
Executive Summary
Momenta plans to seek high court review of the scope of the “Bolar Amendment” in an enoxaparin patent dispute; activity in a second “safe harbor” case at the Supreme Court is expected to resume now that the appeals court proceedings in Momenta v. Amphastar have concluded.